000294115 001__ 294115
000294115 005__ 20250523132249.0
000294115 0247_ $$2doi$$a10.1002/ctm2.70010
000294115 0247_ $$2pmid$$apmid:39439221
000294115 037__ $$aDKFZ-2024-02120
000294115 041__ $$aEnglish
000294115 082__ $$a610
000294115 1001_ $$00009-0007-1943-3286$$aWang, Yuan$$b0
000294115 245__ $$aUnconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer.
000294115 260__ $$aHoboken, NJ$$bWiley$$c2024
000294115 3367_ $$2DRIVER$$aarticle
000294115 3367_ $$2DataCite$$aOutput Types/Journal article
000294115 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1729692557_9810$$xLetter
000294115 3367_ $$2BibTeX$$aARTICLE
000294115 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294115 3367_ $$00$$2EndNote$$aJournal Article
000294115 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000294115 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000294115 7001_ $$aLazaridou, Maria-Filothei$$b1
000294115 7001_ $$0P:(DE-He78)70e630b77e8ddc41353fc23197569b7c$$aKordass, Theresa$$b2$$udkfz
000294115 7001_ $$aMassa, Chiara$$b3
000294115 7001_ $$00000-0003-4765-1719$$aVaxevanis, Christoforos K$$b4
000294115 7001_ $$0P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944$$aEichmüller, Stefan$$b5$$udkfz
000294115 7001_ $$00000-0002-5544-4958$$aSeliger, Barbara$$b6
000294115 773__ $$0PERI:(DE-600)2697013-2$$a10.1002/ctm2.70010$$gVol. 14, no. 10, p. e70010$$n10$$pe70010$$tClinical and translational medicine$$v14$$x2001-1326$$y2024
000294115 8564_ $$uhttps://inrepo02.dkfz.de/record/294115/files/Clinical%20Translational%20Med%20-%202024%20-%20Wang%20-%20Unconventional%20microRNA%20role%20Enhancing%20the%20human%20leukocyte%20antigen%20class%20I.pdf
000294115 8564_ $$uhttps://inrepo02.dkfz.de/record/294115/files/Clinical%20Translational%20Med%20-%202024%20-%20Wang%20-%20Unconventional%20microRNA%20role%20Enhancing%20the%20human%20leukocyte%20antigen%20class%20I.pdf?subformat=pdfa$$xpdfa
000294115 909CO $$ooai:inrepo02.dkfz.de:294115$$pVDB
000294115 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)70e630b77e8ddc41353fc23197569b7c$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000294115 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000294115 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000294115 9141_ $$y2024
000294115 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN TRANSL MED : 2022$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-06-08T15:16:46Z
000294115 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-06-08T15:16:46Z
000294115 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2020-06-08T15:16:46Z
000294115 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-06-08T15:16:46Z
000294115 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bCLIN TRANSL MED : 2022$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000294115 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000294115 9201_ $$0I:(DE-He78)D210-20160331$$kD210$$lGMP-Einheit Zelluläre Therapie$$x0
000294115 980__ $$ajournal
000294115 980__ $$aVDB
000294115 980__ $$aI:(DE-He78)D210-20160331
000294115 980__ $$aUNRESTRICTED